Abstract | Neisseria gonorrhoeae and Neisseria meningitidis are Gram-negative bacterial pathogens that are exquisitely adapted for growth at human mucosal surfaces and for efficient transmission between hosts. One factor that is essential to neisserial pathogenesis is the interaction between the bacteria and neutrophils, which are recruited in high numbers during infection. Although this vigorous host response could simply reflect effective immune recognition of the bacteria, there is mounting evidence that in fact these obligate human pathogens manipulate the innate immune response to promote infectious processes. This Review summarizes the mechanisms used by pathogenic neisseriae to resist and modulate the antimicrobial activities of neutrophils. It also details some of the major outstanding questions about the Neisseria-neutrophil relationship and proposes potential benefits of this relationship for the pathogen.
The genus Neisseria encompasses commensal and patho genic species that colonize human mucosal epithelia. Commensal species, including Neisseria lactamica and Neisseria mucosa, live on the mucosal surface of the nasopharynx and rarely cause disease in healthy indi viduals. By contrast, the pathogenic species Neisseria gonorr hoeae and Neisseria meningitidis, both of which are closely related to commensal Neisseria spp., can induce inflammation and breach mucosal barriers
. The pathogenic neisseriae are closely related and are therefore genetically and physiologically highly similar, but they differ in disease presentation: N. gonorrhoeae causes the prevalent sexually transmitted infec tion gonorrhoea, whereas N. meningitidis causes highly infectious meningococcal meningitis. However, they share the potential for longterm colonization of a sin gle host in the absence of antibiotic therapy. They also both have the genetic flexibility to respond to changes within or between hosts, have similar high transmis sibility between hosts and can increase the possibility of transmission by causing common asymptomatic infections that escape detection and treatment.
The pathogenic neisseriae express a set of common virulence determinants that allow efficient coloniza tion, immune evasion and transmission. Reflecting their high degree of adaptation to humans, rather than produce cytotoxins or other secreted toxic products, these bacteria have evolved specialized mechanisms to promote growth and persistence in the host (TABLE 1) . N. gonorrhoeae and N. meningitidis also express species specific factors that affect their different sites of infec tion, transmission and disease course 1 , although many of these socalled virulence determinants are also expressed by commensal organisms 2 (TABLE 1) . Because it is difficult to separate the properties that facilitate colonization by the pathogenic neisseriae -properties which may be shared among all Neisseria spp. -from those that are crucial for eliciting disease, the features that define the pathogenic species remain obscure.
Given the high degree of adaptation of the patho genic neisseriae to humans, it is noteworthy that the bacteria avoid the host adaptive immune system (BOX 2) and trigger a potent innate immune response involving neutrophils (also known as polymorphonuclear leuko cytes (PMNs)). Infection stimulates the recruitment of neutrophils to the urogenital tract and cerebrospinal fluid (CSF), sites that are normally free of these cells, and the presence of copious numbers of neutrophils at sites of infection is the primary clinical manifestation of disease 3, 4 . As the first responders of the immune system to infection or injury, neutrophils possess cytoplasmic granules that contain many antimicrobial enzymes, pep tides and reactive chemicals 5 . These cells either take up microorganisms by phagocytosis into phagolysosomes,
Phagocytosis
A crucial process by which the immune system clears foreign objects, invading microorganisms and dead or dying cells. Phagocytic cells of the immune system include neutrophils and macrophages; dendritic cells can also undergo phagocytosis.
Phagolysosomes
Intracellular compartments that are capable of degrading material ingested by phagocytic cells. In neutrophils, the phagolysosome is formed when the early phagosome fuses with granules that carry antimicrobial products.
Neutrophil extracellular traps
Chromatin-based structures that are coated with granule proteins and are released from neutrophils to entrap microorganisms. There is currently some debate about whether neutrophil extracellular traps are released from dying neutrophils only, or whether live neutrophils can also produce them.
Apoptosis
Programmed cell death of host cells. The rate and extent of apoptosis in neutrophils and other cells can be influenced by bacterial infection.
which then fuse with the granules to kill the micro organisms inside, or kill microorganisms extra cellularly via granule exocytosis or release of DNArich neutrophil extracellular traps 6 . The prevailing hypothesis empha sized in medical microbiology is that humans are espe cially adept at recognizing and responding to neisserial infections, and this vigorous innate immune response accounts for much of the host damage that accompa nies gonorrhoea and meningococcal meningitis
. But, despite this potent inflammatory response, neutro phils do not clear these infections; viable bacteria can be cultured from CSF in patients with meningo coccal meningitis and from gonorrhoeal secretions, in which neutrophils are plentiful. Moreover, individuals with neutrophil immunodeficiencies are not at increased risk of neisserial infection 3, 4 . These observations sug gest that, instead, the recruitment of neutrophils by pathogenic neisseriae may not be especially deleterious to the bacteria and may in fact enhance the disease causing potential of these pathogens. In this Review, we describe the interaction between the pathogenic neisseriae, N. gonorrhoeae and N. meningitidis, and neutrophils, including the recruitment of neutrophils during neisserial infections, resistance of the bacteria to the extracellular and intracellular antibacterial arsenal of neutrophils, and bacterial modulation of neutrophil phagocytosis, oxidant production and apoptosis. We pro pose a model whereby the interaction between patho genic neisseriae and neutrophils promotes, rather than blocks, the infection cycle.
Initiation of infection and initial immune detection
Host cell binding. An essential first step in initiating human infection is colonization of the target mucosal epithelium (FIG. 1) . The pathogenic neisseriae infect diverse mucosal surfaces, including the urethra, cervix, fallopian tubes, rectum, nasopharynx and conjunctiva 3, 4, 7 . Type IV pili mediate the initial attachment to the apical surface of epithelial cells at most mucosal surfaces, after which opacity-associated proteins (Opa proteins) drive inti mate adherence and internalization 8 . In male volunteers inoculated with N. gonorrhoeae, only piliated bacteria effi ciently colonize and produce symptomatic infection 9, 10 , and the majority of the N. gonorrhoeae cells isolated from the male urethra and from the female genital tract dur ing the proliferative stage of the menstrual cycle express Opa proteins [11] [12] [13] . Additional adhesins and invasins allow the pathogenic neisseriae to infect particular epithelial cell subsets. For example, lipo-oligosaccharide (LOS) with lactoNneotetraose at its terminus can bind the asialo glycoprotein receptor on urethral cells; the pilus and the porins interact cooperatively with complement receptor 3 (CR3) on cervical epithelium; and 'moonlighting' bacte rial proteins such as ribosomal protein L12 bind the lutro pin receptor on endometrial cells [14] [15] [16] [17] . Adhesins specific to N. meningitidis, including outermembrane protein C (Opc) and neisserial adhesin A (NadA), target receptors on epithelial and other cells that the bacterium encounters after penetration of the nasopharynx, including those in the bloodstream and meninges 18, 19 .
Detection by the innate immune system. Like many other bacteria, pathogenic neisseriae are detected by mucosal epithelial cells and by the sentinel immune cells in the epithelium, which may include T helper 17 (T H 17) cells, macrophages and dendritic cells [20] [21] [22] . These cells can detect infection or injury via the membrane associated Tolllike receptor (TLR) and cytoplasmic NODlike receptor (NLR) families of pattern recognition receptors 23, 24 , and they therefore participate in the recognition of pathogenic neisseriae. LOS is a potent activator of the TLR4-CD14 complex, and porins and lipoprotein H.8 engage TLR2 . Furthermore, peptidoglycan fragments in outermembrane vesicles are recognized by NLRs in the cytoplasm of epithelial cells 28 . As a consequence, infection by pathogenic neisse riae promotes local release of interleukin8 (IL8), IL6, tumour necrosis factor, IL1β and other cytokines, creat ing a microenvironment that efficiently recruits and acti vates neutrophils [29] [30] [31] [32] [33] (FIG. 1) . Movement of neutrophils to the site of infection follows a welldescribed series of events, starting with increased adhesion to the vascula ture, followed by transendothelial migration and cross ing of subepithelial tissues and ending with entry into the infected epithelium 34 . In male volunteers experimen tally infected with N. gonorrhoeae, neutrophil recruit ment to the urethra occurred, on average, 2-3 days after infection, and the appearance of neutrophils in the urine was rapidly followed by the onset of dysuria and other symptoms consistent with acute disease 13, 35 . A similar timing of neutrophil recruitment has been observed in the mouse genital tract model of gonococcal infec tion 36 . By contrast, the timing of neutrophil recruitment to the meninges in response to N. meningitidis is less well established, but the appearance of neutrophils in the CSF is used to help diagnose meningitis caused by N. meningitidis and other bacteria 4 .
Box 1 | Neisserial disease
Neisseria gonorrhoeae and Neisseria meningitidis cause an estimated 88 million cases of gonorrhoea and 500,000 cases of meningococcal meningitis, respectively, worldwide per year 4, 150 . As obligate human bacterial pathogens, they are highly evolved for colonization of human mucosal epithelial surfaces 3, 4 . Gonococci engage the epithelial surfaces encountered during sexual transmission, such as the male urethra, female cervix, the rectum and the pharynx. Whereas most urethral infections produce symptoms including dysuria and purulent discharge, infections of the cervix, rectum and pharynx are frequently asymptomatic, which complicates the diagnosis and treatment of gonorrhoea and contributes to its persistence 7 . Vertical transmission during childbirth can result in neonatal conjunctivitis.
N. meningitidis colonizes the nasopharynx of ~10% of the human population, although this can be much higher during seasonal epidemics in the African 'meningitis belt' and during other outbreaks. Only a small percentage of individuals colonized with N. meningitidis present with the invasive diseases of meningitis and meningococcaemia 4 . The clinical hallmark of infection by the pathogenic neisseriae is a host innate immune-driven inflammatory response, characterized by a potent neutrophil influx. The subsequent tissue damage enables bacterial access to secondary anatomical sites, which promotes much of the morbidity and mortality associated with neisserial infections. For N. meningitidis, these sites include the bloodstream, the skin and the meninges, and for N. gonorrhoeae they include the fallopian tubes, heart, skin and joints. At these sites, infection by pathogenic neisseriae has adverse outcomes, including disseminated intravascular coagulation and septic shock for N. meningitidis, and pelvic inflammatory disease, dermatitis, endocarditis and arthritis for N. gonorrhoeae. 
Adhesins
Molecules that are expressed on a cell to mediate adherence to another surface.
Lipo-oligosaccharide
(LOS). The main component of the outer leaflet of the outer membrane of Gram-negative bacteria. LOS is similar to lipopolysaccharide (LPS) but lacks the long sugar chain (the O antigen). Pathogenic neisseriae produce different LOS isotypes owing to phase variation of glucosyltransferases for LOS.
Pilus
A fibre that extends from the bacterial cell surface to mediate adherence to a host cell.
Porins
Bacterial outer-membrane, channel-forming proteins. Neisserial porins have been reported to translocate into human cells and affect mitochondrial membrane potential, cell lifespan and the neutrophil-mediated oxidative burst.
Survival of neisseriae after neutrophil exposure Neutrophils have potent intracellular and extracellular antimicrobial activities. Neutrophil extracellular traps and reactive oxygen species (ROS) combat extracellular microorganisms, whereas bacteria that are taken up by neutrophils are transported into a phagosome that contains ROS, degradative enzymes and antimicrobial peptides. In vivo, neutrophils are closely associated with both pathogenic neisseriae: gonorrhoeal exudates and the CSF from patients with meningococcal men ingitis reveal bacteria attached to and inside neutro phils. However, as these fluids contain viable bacteria, pathogenic neisseriae must possess mechanisms that allow them to survive both the intracellular and extra cellular antimicrobial mechanisms of neutrophils. As described below, pathogenic neisseriae can modulate phagocytosis by neutrophils, but even those bacteria that are internalized can circumvent the intracellular antibacterial activities of the host.
Resistance to extracellular antimicrobial mechanisms.
Neutrophils kill adherent microorganisms through localized granule exocytosis and extracellular produc tion of ROS 37 . Neutrophils also produce neutrophil 
Box 2 | Interactions of pathogenic neisseriae with the adaptive immune system
Infection by the pathogenic species Neisseria gonorrhoeae and Neisseria meningitidis is poorly controlled by the adaptive immune system owing to high-frequency antigenic variation of three major surface antigens: lipo-oligosaccharide (LOS), opacity-associated (Opa) proteins and type IV pili 59 . Variation of LOS and Opa proteins is mediated by the random switching on and off (phase variation) of accessory LOS glycosyltransferases or complete opa genes. Both switches occur via changes in nucleotide repeat numbers during DNA replication, altering the reading frame of the affected gene and subsequent protein production 65, 151 . Pili vary by gene conversion between silent storage copies of variant pilin information (the multiple copies of pilS) and the single expressed pilin gene (pilE) 152 ; pili also phase vary through changes in nucleotide repeat number in the pilC genes (which maintain pilus expression on the bacterial surface) 153 . Thus, every population of pathogenic Neisseria spp. has subpopulations of bacteria that express antigenically distinct surface structures. It is assumed that antibodies reacting with any of these three antigens could block infection, providing the selective pressure for evolution of such complex antigenic and phase variation mechanisms. However, switching of LOS, Opa protein or pilus expression states also alters bacterial interactions with host cells such as neutrophils (see main text). N. gonorrhoeae has the genetic capacity to generate much more diversity in these surface antigens than N. meningitidis, presumably reflecting the greater chance of gonococcal transmission and reinfection. Whereas certain N. meningitidis capsular polysaccharides elicit a protective antibody-mediated immune response in immunized individuals -and these polysaccharides are the basis of the current quadrivalent vaccines -the presence of a capsule composed uniquely of sialic acid on serogroup B N. meningitidis makes this serogroup poorly immunogenic and refractory to vaccine-mediated protective immunity 4 . The pathogenic neisseriae also directly modulate adaptive immune functions. N. gonorrhoeae and N. meningitidis secrete an immunoglobulin A1 (IgA1) protease that can directly inactivate certain classes of secretory IgA in mucosal secretions 154 . Protease expression may prevent IgA-mediated opsonization of the bacteria to block phagocytosis through IgA receptors on neutrophils and other cells, and to prevent complement-mediated lysis. IgA1 protease also cleaves the human lysosome-associated membrane glycoprotein 1 (LAMP1) 155, 156 , which localizes to the lysosomes of cells, including neutrophils. However, the role of IgA1 protease in infection with pathogenic neisseriae is enigmatic, as an IgA1 protease-mutant N. gonorrhoeae retains infectivity in the male urethral-challenge model . The pathogenic neisseriae also downregulate CD4 + T cell function 143 and kill B cells 144 in CEACAM1-dependent manners. Along with the inability of live pathogenic neisseriae to fully activate antigen-presenting cells such as dendritic cells 158 , these results imply that during infections with pathogenic neisseriae there is a localized immune suppression that would contribute to long-term bacterial persistence in the host. 
Pattern recognition receptors
A family of proteins that recognize families of foreign objects, including evolutionarily conserved products of microorganisms, such as lipopolysaccharide and peptidoglycan. Common pattern recognition receptors include proteins of the Toll-like receptor family and the NOD-like receptor family. extracellular traps, which capture and inactivate bacteria at a distance from the neutrophil surface 6 . Despite these mechanisms, neutrophils are not especially adept at kill ing extracellular bacteria; when N. gonorrhoeae is incu bated in the presence of neutrophils in vitro, >80% of extracellular bacteria remain viable, and neutrophils in which phagocytosis is inhibited possess a limited ability to kill N. gonorrhoeae 38 . At least one N. gonorrhoeae viru lence factor, the metalloproteinase NGO1686 (which is also encoded in meningococcal genomes), protects the bacterium from extracellular killing by neutrophils 38, 39 . This observation supports the contention that N. gonorrhoeae, and potentially N. meningitidis, can withstand the extracellular antimicrobial activities of neutrophils when phagocytosis has not occurred.
Prevention of phagocytosis.
The pathogenic neisse riae avoid phagocytosis by neutrophils in three ways: by preventing their binding to the neutrophil surface, by limiting the deposition of opsonic antibody or complement on the bacterial surface and by varying antigenic surface structures to evade humoral immunity (FIG. 2a) .
As phagocytosis requires close apposition between the neutrophil and bacterial membranes, one effective strategy to avoid phagocytosis is to physically block this interaction. N. meningitidis produces a polysac charide capsule that prevents phagocytosis by increas ing the negative charge of the bacterial surface 40 . Many different capsular serotypes have been described for N. meningitidis, six of which are associated with epi demic disease (A, B, C, W135, X and Y) 41 . N. gonorrhoeae does not produce a capsule. Interestingly, capsule expression in N. meningitidis can be turned on and off during the bacterial life cycle, suggesting that there are points in the life cycle at which capsule production is disadvantageous, such as when inside a host cell 41, 42 . It was originally thought that the type IV pili of pathogenic neisseriae, which extend several micrometres from the bacterial outer membrane, were antiphagocytic 43 , but most research has refuted this idea 44, 45 . Efficient phagocytosis of bacteria is driven by opsoni zation with antibody and/or complement. Therefore, bacteria can avoid phagocytosis by preventing anti body or complement deposition. The meningococcal capsule masks bacterial surface antigens that can be recognized by antibodies, complement or lectintype phagocytic receptors. This masking not only blocks opsonophagocytosis but also confers resistance to com plementmediated killing 46, 47 . The pathogenic neisse riae also prevent antibody deposition by incorporating sialic acid (Nacetylneuraminic acid) into their surface structures. As sialic acid is also found on the surface of mammalian cells, it is not antigenic to the immune sys tem. Because antibodies are not raised against sialylated moieties on bacterial surface structures, sialylation inhib its opsonophagocytosis of the bacteria. Sialic acid is the major component of the serogroup B N. meningitidis capsule and is also part of the capsules of serogroup C, W135 and Y N. meningitidis 41 . Furthermore, the termi nal galactose residue of LOS from pathogenic neisseriae is sialylated by the α2,3sialyltransferase, encoded by lst 48 .
Reflecting the high degree of adaptation of the pathogenic neisseriae to humans, the activated sialic acid substrate for the sialyltransferase, cytidine monophosphoNacetyl muramic acid, is produced by human cells, not the bacte ria 49 . Bacteria with sialylated LOS have enhanced survival in the presence of human and mouse neutrophils 50 and are also more resistant to complementmediated killing 51 . The pathogenic neisseriae also limit complement mediated phagocytosis by binding the complement cas cade inhibitors complement factor H and complement factor 4bbinding protein (C4BP). Complement factor H directly interacts with the N. gonorrhoeae porin PorB1A (encoded by porB) and sialylated LOS, and N. meningitidis also produces complement factor Hbinding lipo protein and neisserial surface protein A (NspA) [52] [53] [54] [55] . C4BP binds to the PorA porin of N. meningitidis (encoded by porA) and to both PorB1A and PorB1B (also encoded by porB) of N. gonorrhoeae, contributing to bacterial serum resistance 56, 57 . The association between variants Although pathogenic neisseriae colonize diverse mucosal surfaces in the human body, we have only a limited understanding of how differences in these diverse environments create challenges and opportunities for the bacteria 4, 7 . Pathogenic neisseriae use type IV pili, opacity-associated (Opa) proteins and other adhesins to colonize and occasionally invade the mucosal epithelium. Bacterial products such as lipo-oligosaccharide (LOS), peptidoglycan and lipoproteins, which are released either as free compounds or in outer-membrane vesicles, stimulate NOD-like receptor (NLR) and Toll-like receptor (TLR) family pattern recognition receptors on epithelial cells and immune cells such as dendritic cells (DCs), macrophages and T cells. As a result, gradients of pro-inflammatory cytokines, including interleukin-6 (IL-6), IL-8, IL-1β, interferon-γ and IL-17, are established. The cytokines recruit neutrophils and induce their migration across the epithelium, where they bind and phagocytose the bacteria. 
Reactive oxygen species (ROS)
. A family of chemicals that are oxidized versions of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals. ROS are produced by neutrophils via the action of NADPH oxidase and exert antimicrobial activities by damaging lipids, carbohydrates, proteins and nucleic acids.
Opsonic
Coating a particle to facilitate its uptake by phagocytes. Common opsonins are immunoglobulins (antibodies) and complement.
Complement
A system of >25 proteins that recognize foreign objects and target them for destruction or phagocytosis. The complement proteins undergo sequential proteolytic events, resulting in activation of the membrane attack complex, a pore that forms on the surface of the foreign object to rupture it. Complement proteins such as C3b and C4b are recognized by complement receptors, and this triggers phagocytosis of the complement-opsonized particle.
Capsule
The polysaccharide coating found on N. meningitidis that alters the bacterial cell surface and its interactions with other cells and molecules.
CEACAM receptors
(Carcinoembryonic antigen-related cell adhesion molecule receptors). A family of host proteins that are expressed on a variety of cell types to mediate intercell communication. They serve as receptors for opacity-associated (Opa) proteins. of the human complement factor H gene and serious meningococcal disease 58 , and the observation that indi viduals lacking terminal complement components (such as C6) are more susceptible to meningococcal infection 4 , underscores the importance of evading complement deposition in neisserial pathogenesis.
The pathogenic neisseriae avoid antibodymediated opsonization by varying the antigenic surface struc tures. N. gonorrhoeae and N. meningitidis undergo high frequency variation in the expression and composition of LOS, Opa proteins and type IV pili 59 
. By con tinually varying the antigens that are presented to the host immune system, the bacteria stay one step ahead of the humoral immune response, thereby preventing antibody binding to the bacterial surface and subsequent phagocytosis through immunoglobulin receptors.
Phagocytosis of neisseriae.
Although the pathogenic neisseriae can avoid phagocytosis in various ways, numerous bacteria are detected inside neutrophils from patients with gonorrhoea or meningococcal meningi tis (in fact, the original name for N. meningitidis was Diplococcus intracellularis 4 ). Experimental evidence sug gests that both opsonized and nonopsonized bacteria can be phagocytosed by neutrophils (FIG. 2b) . Generally, when a particle engages immunoglobulin or comple ment receptors on neutrophils, it is internalized into a phagosome that fuses with cytoplasmic granules. This produces an acidified phagolysosome containing ROS, degradative enzymes and antimicrobial peptides, a toxic combination 60 . Although the pathogenic neisseriae have evolved extensive mechanisms for evasion of comple ment and antibodies, as described above, convalescent serum from patients with meningococcal meningitis contains Neisseria spp.reactive antibodies, and comple ment factors C3b and C4b can be fixed on the bacterial surface 4, 61 . These findings suggest that a fraction of the pathogenic neisseriae is subjected to opsonophagocytosis during infection.
In the absence of opsonization, the outermembrane Opa proteins mediate internalization of the pathogenic neisseriae by neutrophils. N. meningitidis and N. gonorrhoeae encode up to 11 and five different Opa proteins in their genomes, respectively [62] [63] [64] ; most research has focused on the gonococcal Opa proteins. Each Opa encoding gene independently undergoes phase varia tion through a pentameric repeat in the DNA sequence encoding the signal peptide, such that there are both Opa + and Opa -bacteria in the population, and some Opa + bacteria express multiple Opa proteins 65 . The majority of Opa proteins are recognized by one or more of the human CEACAM receptors (these Opa proteins are referred to here as Opa CEA proteins), a more restricted subset binds hep aran sulphate proteoglycans (referred to here as Opa HS proteins) and some Opa proteins engage both types of protein 66 . N. gonorrhoeae expressing defined Opa CEA pro teins undergoes enhanced phagocytosis and killing 45, [67] [68] [69] [70] . Moreover, heterologous expression of Opa CEA proteins in Escherichia coli is sufficient to promote phagocytosis by neutrophils 71 , and N. gonorrhoeae outermembrane vesi cles containing Opa proteins, or purified Opa proteins reconstituted in liposomes or detergent micelles, inhibit the interaction of homologous Opa + bacteria with neutro phils 72 . Thus, Opa CEA proteins are important mediators of neutrophilmediated phagocytosis of pathogenic neisseriae.
The CEACAMs are members of the immunoglobu lin superfamily of cell adhesion receptors and mediate intercellular associations that are important for tissue structure, neovascularization and insulin responsive ness; importantly, CEACAMs are used as receptors by nonneisserial humanspecific bacterial pathogens that live at mucosal surfaces, including Moraxella catarrhalis and Haemophilus influenzae 73 . It has been proposed that CEACAM3, which is expressed only by neutrophils and other granulocytes, evolved to assist neutrophils in clearing these bacteria [74] [75] [76] . CEACAM1 and CEACAM6 are also expressed by neutrophils [77] [78] [79] [80] [81] , and human CEACAM1, CEACAM3, CEACAM5 and CEACAM6 all bind neis serial Opa CEA proteins through an interaction of their aminoterminal immunoglobulin variablelike domain with the hypervariable loops of Opa CEA 82, 83 . CEACAM1, CEACAM3 and CEACAM6 possess multiple extra cellular immunoglobulinlike domains, and each protein transduces different intracellular signals. Membrane spanning isoforms of CEACAM1 have two cytoplasmic immunotyrosine inhibitory motifs (ITIMs) that block cytokine production and proliferation in T cells 84 . By contrast, transmembrane isoforms of CEACAM3 have a cytoplasmic immunotyrosine activation motif (ITAM) that stimulates kinasedependent signalling events in neutrophils, culminating in phagocytosis, ROS pro duction and killing of Opa CEA + N. gonorrhoeae [85] [86] [87] . The glycophosphatidylinositol (GPI)anchored CEACAM6 and 'short' isoforms of CEACAM1 and CEACAM3 require transmembrane CEACAMs or other receptors to transduce signals 73, 84 . Intriguingly, CEACAM1 and CEACAM6 potentiate, rather than impede, CEACAM3 signalling in neutrophils infected with high numbers of N. gonorrhoeae 88 . This observation helps explain why N. gonorrhoeae that binds only CEACAM1 promotes ROS production 89 and bacterial killing 90 by neutrophils. Opa CEA + N. gonorrhoeae survives less well after exposure to neutrophils in vitro than its Opa -counter part 68, 69 . However, Opa + N. gonorrhoeae is commonly recovered from the urethra of men with uncomplicated gonorrhoea and from the cervix of women in the pro liferative phase of the menstrual cycle, two sites where neutrophils are also commonly found during neisserial infection, suggesting that at least some Opa + bacteria survive neutro phil surveillance despite recognition by CEACAM3 (REFS 11-13). At least two possibilities could explain the in vivo selection for Opa + neisseriae despite their increased sensitivity to killing by neutrophils. The first possibility is that the selective pressure to maintain Opa expression for bacterial binding and uptake by epithelial cells outweighs the detrimental effect of Opa expression on survival after exposure to neutrophils. With this in mind, it is intriguing that a subset of neis serial Opa CEA proteins are recognized by other human CEACAMs but not by CEACAM3 (REFS 79, 81 these specific Opa proteins to maintain the capacity for mediating epithelial colonization while avoiding clear ance by neutrophils through CEACAM3 (REF. 76 ). As Opa expression is phase variable, a proportion of the bacterial population can avoid CEACAM3dependent phagocytosis and killing by neutrophils, ensuring per sistence of some bacteria in the human host. The second possibility, as discussed below and suggested by in vitro evidence, is that not all internalized Opa + neisseriae are killed by neutrophils. The pathogenic neisseriae may in fact exploit Opa CEA protein expression to drive their own uptake into neutrophils, which may provide the bacteria with advantages inside the host.
As well as the Opa proteins facilitating phagocytosis of nonopsonized neisseriae, adherent and chemokine primed primary human neutrophils have been shown to internalize nonopsonized Opa -N. gonorrhoeae 38 . Opsoninindependent, Opaindependent phagocytosis of the pathogenic neisseriae may occur in three ways. First, neutrophils may use an unknown receptor to bind to N. meningitidis producing lactoN-neotetraose containing LOS 91 . Second, pathogenic neisseriae may engage CR3 through a cooperative interaction between type IV pili and the porin PorB1B, as described for the N. gonorrhoeae interaction with cervical epithelial cells 17 . Third, the pathogenic neisseriae may be small 
Oxidative burst
The production of reactive oxygen species (ROS) through the action of the NADPH oxidase enzyme.
enough (less than 1 μm in diameter) to be internalized by receptorindependent macropinocytosis. It is clear that the surface variability of the patho genic neisseriae contributes to complex interactions with neutrophils that can either activate or inhibit phago cytosis and antibacterial activities. It will require sys tematic investigation with defined variants and mutants to determine how the expression of different bacterial surface ligands alters phagocytosis and whether these interactions dictate different fates for the bacteria within neutrophils (see below).
Neisserial survival inside neutrophils. Phagocytosis by neutrophils is generally a dead end for bacteria. However, a fraction of the pathogenic neisseriae seems to survive and replicate inside neutrophils. Electron microscopy studies revealed the presence of electrondense, intact bacteria inside neutrophils from inflammatory exudates 44, [92] [93] [94] , and through the use of membraneimpermeant antibiotics it was shown that the number of intracellular N. gonorrhoeae cells and the number of bacteria per intracellular phagosome inside neutrophils increase over time [95] [96] [97] . This occurs for both serumopsonized, Opa + and non opsonized, Opa -N. gonorrhoeae, suggesting that the route of entry does not affect the eventual replication of the bacteria inside cells 38, 98 . Although it is formally possible that the increase in bacterial numbers inside neutrophils is due to continual phagocytosis of live extracellular bacteria, and the increase in numbers of bacteria per phagosome results from fusion between phagosomes, these findings strongly suggest that N. gonorrhoeae, and potentially also N. meningitidis, survives and replicates inside neutrophils. Pathogenic neisseriae may persist inside neutrophils as a result of their intrinsic resistance to neutrophil antimicrobial factors and by interfering with the release of these factors.
Preventing neutrophil apoptosis. As neutrophils are terminally differentiated cells with a halflife of several hours, internalization by these cells could be considered a dead end for Neisseria spp., unless the lifespan of these immune cells could be increased. To this end, the patho genic neisseriae modulate the apoptosis programmes of neutrophils and of other human cells. Experiments primarily using cultured immortalized epithelial cells have revealed both pro and antiapoptotic effects of pathogenic neisseriae [99] [100] [101] [102] . Modulation of apoptosis has been linked to translocation of neisserial porin to the mitochondrion, a process which may require other factors, such as Omp85 (REF. 103 ). However, the mechanism by which the translocated porin modu lates apoptosis remains unknown 102, 104 . Modulation of apoptosis by a porin may also occur in neutrophils, as infection by N. gonorrhoeae extends the lifetime of some primary human neutrophils by delaying spon taneous apop tosis 33, 105 , in contrast to phagocytosis of most bacteria, which triggers apoptosis 106 . This length ening of the neutrophil lifespan by pathogenic neisse riae supports the idea that these bacteria can modulate neutro phils to gain an advantage during infection of the human host.
Disarming neutrophils
Whether bacteria are inside or outside neutrophils, there are two basic mechanisms that can be invoked to explain survival of the pathogenic neisseriae among neutrophils. First, the bacteria could possess inherent resistance to neutrophil antimicrobial factors. There is strong genetic and biochemical evidence that specific gene products can resist neutrophil factors, but in many cases these protective gene products have not been directly evaluated in the context of intact neutrophils. Second, the bacteria could respond to and downregulate the antimicrobial activities of neutrophils -for exam ple, by delaying neutrophil apoptosis and modulating release of neutrophil antimicrobial products. Given the high degree of host adaptation by the pathogenic neisse riae, it is not surprising that there is evidence that both mechanisms can act to promote bacterial survival after exposure to neutrophils.
Neisserial resistance to neutrophil-mediated oxidative damage. One of the best described antimicrobial properties of neutrophils is the oxidative burst. Activated neutrophils assemble the multisubunit NADPH oxidase enzyme on the phagosomal or plasma membrane 107 (FIG. 2c) . NADPH oxidase generates superoxide, which spontaneously or catalytically dismutates to hydrogen peroxide; in turn, hydrogen peroxide is used by the neutro phil granule enzyme myeloperoxidase to produce hypochlorous acid. These ROS are microbicidal owing to their ability to damage lipids, proteins and nucleic acids 108 .
To defend against ROS, the pathogenic neisseriae encode several proteins that directly detoxify these compounds (including catalase, cytochrome c peroxi dase and superoxide dismutase) or quench them (such as the Mnii transport system (MntABC)), or that repair oxidatively damaged DNA and proteins (such as MutY, RecA, the Uvr system and MsrAB) [109] [110] [111] [112] [113] [114] [115] [116] [117] (FIG. 2c) . In addi tion, N. meningitidis counters ROS by using lglutamate transporter (GltT) to acquire lglutamate, which is con verted to glutathione and helps maintain cytoplasmic redox potential during ROS exposure 118 . Additional proteins that protect against ROS include the gono coccal metalloproteinase NGO1686 and the proteins encoded in the NMB1436-1438 operon in N. meningitidis 39, 119 . In N. gonorrhoeae str. FA1090, transcription of many of these genes is increased following exposure to sublethal concentrations of oxidants, suggesting the presence of transcriptionregulatory circuits that protect the bacteria from oxidative stress 39 . The pathogenic neis seriae also possess at least three means of inhibiting the production of ROS by neutrophils. Exposure to lactate, a byproduct of neutrophil glycolysis, enhances bacterial consumption of molecular oxygen, which depletes the substrate for NADPH oxidase and thus blunts the oxida tive burst 120 . Viable Opa -N. gonorrhoeae can also suppress ROS production through a process that requires metaboli cally active bacteria and direct contact with neutrophils 121 . Finally, purified porin can translocate into cells and, sub sequently, into the mitochondria by a poorly understood mechanism to block ROS production 122 .
Despite the presence of many bacterial antioxidant defences, there is mounting evidence that ROS have a minimal role in neutrophil killing of Neisseria spp. dur ing infection. Mutants lacking antioxidant gene products, singly or in combination, survive neutrophil exposure similarly to wildtype bacteria 38, 123 . Moreover, chemical or genetic inhibition of neutrophil NADPH oxidase 38, 68, 124, 125 , or incubation with neutrophils in anoxic conditions 126 , does not affect bacterial survival after exposure to human or mouse neutrophils. Although some Opa + bacteria induce ROS production by neutrophils, NADPH oxi dase activity does not affect bacterial survival in neutro phils 38, 124 . Even the survival of gonococcal NGO1686 and recN mutants, which are significantly more sensitive to ROS and to the antibacterial activities of neutrophils than their wildtype counterparts, is unaffected by NADPH oxidase inhibition 38 . Together, these observations show that neutrophilmediated activity against pathogenic neisseriae and the production of ROS are separable pheno types. Notably, there are other host sources of ROS besides neutrophils. Several N. gonorrhoeae strains with mutations in genes encoding antioxidant proteins have survival defects in primary human cervical epithelial cells and in the mouse genital tract, implying that these cells and tissues produce ROS 126, 127 . Commensal lacto bacilli that are present in the female genital tract can also generate hydrogen peroxide, although evidence from mouse models, as well as studies using human secretions, suggests that this source of ROS does not significantly affect gonococcal survival 128, 129 . One reason that the oxidative burst may be dispensa ble for the antibacterial activities of neutrophils against Neisseria spp. is that the bacteria use multiple mecha nisms to defend themselves against ROS. We specu late that in early stages of infection by the pathogenic neisseriae, when few bacteria are present and most are viable, host ROS production is minimal and antioxidant proteins protect the bacteria sufficiently. However, more ROS are produced when the number of Opa + bacteria increases and a sizable population of nongrowing bacte ria forms, leading to increases in the levels of inflamma tory products such as LOS. We hypothesize that the ROS produced by neutrophils and other host cells acts as a signal to the bacteria that inflammation has commenced and, in response, the bacteria initiate a transcriptional programme that is protective against oxidative and non oxidative host damage. As support for this hypothesis, pretreatment of N. gonorrhoeae with hydrogen peroxide enhances bacterial survival in primary human neutro phils independently of the oxidative burst 38 . Thus, the pathogenic neisseriae exploit the oxidative arsenal of the host by using it to induce the production of additional defences against neutrophils.
Neisserial resistance to neutrophil-mediated non-oxidative damage. As oxidative products are dispensable for neutrophilmediated antimicrobial activities against pathogenic neisseriae, other, nonoxidative antibacterial factors of neutrophils must act on the bacteria, although the presence of viable neisseriae in the presence of neu trophils implies that these factors are not sufficient to clear infection. The nonoxidative antibacterial factors in neutrophils include degradative enzymes (such as lysozyme, elastase and cathepsin G), cationic peptides (such as defensins and the cathelicidin LL37) and the vesicular protonATPase, which lowers the pH of the phagosome 130, 131 . Many of these factors are also present at mucosal surfaces and have important functions in pro tecting the host. For example, LL37 is present in mucosal secretions, and the female genital tract has a low pH.
Many proteins of pathogenic neisseriae protect the bacteria after exposure to nonoxidative antibacterial factors in vitro. The multiple transferable resistance sys tem (MtrCDE) and fatty acid resistance system (FarAB) efflux pumps play a prominent part in conferring resist ance to antibiotics, free fatty acids, detergents and anti microbial peptides 132, 133 . Gonococcal mutants lacking the MtrCDE efflux pump do not colonize the mouse genital tract as well as wildtype bacteria 134 , but it is not known whether this is due to nonoxidative functions of genital neutrophils, increased sensitivity of the mutants to the antimicrobial peptides in mucosal secretions or both. The MisRS (also known as PhoPQ) twocomponent regulatory system, which promotes resistance to anti microbial peptides in Neisseria spp. and other patho gens 135 , directly and indirectly regulates various genes in Neisseria spp. One of the gene products in the MisRS reg ulon, lipopolysaccharide transporter periplasmic protein (LptA), adds a phosphoethanolamine moiety to LOS 136, 137 . Meningococcal LptA confers resistance to antimicrobial peptides as well as complement 138 . Other gene products that defend pathogenic neisseriae against nonoxidative factors include the meningococcal proteins NMB0741 and NMB1828, which provide protection against catheli cidins 139 , and peptidoglycan Oacyltransferase (PacA), which Oacetylates peptidoglycan to render it resistant to lysozyme 140 . In addition, the N. meningitidis capsule confers resistance to antimicrobial peptides 42 . One of the major gaps in our understanding of the interactions between neutrophils and pathogenic neis seriae is how the virulence properties that defend the bacteria against nonoxidative factors in vitro affect bac terial survival after neutrophil challenge. To date, only the gonococcal NGO1686 and RecN proteins have been shown to promote bacterial survival after neutrophil exposure independently of NADPH oxidase activity 38 , and how these proteins mediate their effect is not cur rently understood. Many other proteins confer resistance to nonoxidative antimicrobial factors derived from neutro phils, but their role in protecting the bacteria from clearance by neutrophils remains unexplored.
Neutrophils may promote neisserial pathogenesis
Successful pathogens create a niche in their hosts for nutrient acquisition and a means of effective transmis sion to new individuals, all the while limiting deleterious effects on the health of the host. As bacteria that are well adapted to their host, the pathogenic neisseriae possess unique mechanisms to evade and subvert host immune responses. On the basis of this adaptation, we posit that these bacteria actively recruit neutrophils for intra and interhost dissemination, in a mechanism similar to that 
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proposed for Staphylococcus aureus 141 . As described above, the pathogenic neisseriae meet several criteria that would support this contention: neutrophils are recruited in unusually high numbers at sites of infection, the bacteria survive and replicate in and around neutro phils, and the bacteria use dedicated proteins to defend against killing mechanisms in neutrophils and modu late neutrophil activities. These pathogenic mechanisms have not necessarily evolved to maximize the survival of any individual bacterial cell, but probably function on a populationwide scale, enabling a subset of bacteria to undergo replication, dissemination and transmission (FIG. 3) . As elaborated on below, we speculate that these pathogens actively associate with neutrophils to help themselves acquire nutrients, to create a protective niche from the immune system and to allow transmission to tissues deeper in the body and even to other hosts.
Nutrient acquisition.
The pathogenic neisseriae reside primarily on the surface of epithelial cells, where the lim ited nutrient flow in mucosal secretions restricts bacte rial replication. As part of the inflammatory response to infection by pathogenic Neisseria spp., neutrophil influx causes leakage of serum components and damage to sur rounding tissues, both of which would liberate nutrients for extracellular bacteria. Phagocytosis of the bacteria by neutrophils may allow pathogenic neisseriae access to intracellular nutrient pools, including concentrated sources of iron, such as holotransferrin and lactoferrin, for which these bacteria have receptors 142 .
Creating a protective niche. When inside neutrophils, the bacteria reside within phagosomes, which protect the pathogens from humoral immune surveillance. Neutrophils are not thought to function as antigen presenting cells, so persistence inside neutrophils may also protect the bacteria from potentially toxic sources of cellmediated immunity, such as cytotoxic T lympho cytes. Of course, phagocytosis of a dead, infected neutro phil by a macrophage would represent a dead end for the bacteria inside and would amplify the humoral immune response. However, infection by pathogenic neisseriae can prolong the neutrophil lifespan, and these bacteria provide a general immune suppression to dampen adap tive immune responses 143, 144 . These two features would contribute to the persistence of the pathogens when in association with neutrophils.
Access to deeper and ascendant tissues. A small fraction of the pathogenic neisseriae transit across epithelial and endothelial monolayers, but in general these bacteria are not particularly motile; the one organelle associated with motility, the type IV pilus, in fact counters dissemina tion by driving the formation of bacterial microcolonies that enhance attachment to host tissues 145 . The presence of neutrophils would facilitate bacterial access to sec ondary sites of infection in two ways. First, the influx of neutrophils and the associated inflammatory milieu produces local tissue damage, creating breaches in epi thelial integrity through which the bacteria could pass 146 . Second, as recently suggested, neutrophils themselves may carry viable bacteria to new sites 147 . Activated neutrophils could carry N. meningitidis throughout the nasopharyngeal epithelium or aid N. gonorrhoeae ascension to the upper reproductive tract. Retrograde (tissuetobloodstream) movement of neutrophils in sterile injury has been reported 148 ; if this were to occur during infection with a pathogenic neisserial species, neutrophils could also transport the bacteria into the bloodstream to aid dissemination. Neutrophildriven movement of neisseriae has not yet been visualized, but it would promote the main outcomes of N. meningitidis infections -meningococcaemia and meningitis -and would also lead to disseminated gonococcal infection and associated arthritis, endocarditis and dermatitis.
Transmission to new hosts. N. gonorrhoeae survives poorly, if at all, outside the human body, whereas cap sulated N. meningitidis can survive for a limited dura tion on fomites and solid surfaces 3, 4 . It is tempting to speculate that neutrophils serve as a conduit for trans fer of meningococci and gonoccoci to receptive hosts. Although there is no direct evidence for transfer of neu trophils between individuals, there is a possibility that mechanisms in addition to the transfer of free bacteria are important for the high frequencies of transmission between hosts -for instance, in the transfer of N. gonorrhoeae from women to men. Taking this into account, the acute inflammation associated with gonorrhoea could be a response to foreign neutrophils as well as to the bacteria 3 . Perturbations in the epithelium during neutrophil infiltration enhance the influx of serum and associated nutrients for extracellular neisseriae. Neisseriae that have been phagocytosed by neutrophils may be able to access nutrients from inside the phagosome. Intracellular neisseriae avoid surveillance by humoral immunity. Attachment or phagocytosis by motile neutrophils promotes bacterial movement to deeper or ascendant tissues and transmission to new hosts.
Conclusions
Many crucial questions about the interactions between pathogenic neisseriae and neutrophils remain to be addressed. For instance, how do the bacteria survive and replicate in a cell type that is optimized for antibacterial function? How does the plethora of proteins that pro tects the bacteria from purified hostderived compo nents in vitro contribute to persistence during infection? What are the mechanisms by which pathogenic neisse riae modulate neutrophil functions (ROS production, release of antimicrobial components and apoptosis)? This last question is especially intriguing considering that virulenceassociated secretion systems and produc tion of exotoxins are highly reduced or absent in these bacteria 149 . Defining the ultimate fate of the bacteria dur ing neutrophil infection will require a system for follow ing the entire infection process, from initial exposure to establishment of chronic infection. As ethical considera tions preclude the parallel examination of Neisseria spp. within neutrophils in the human host, animal models, including transgenic mouse models, will probably pro vide the appropriate system 36 . Given the recent exciting developments in the study of the interactions between pathogenic Neisseria spp. and neutrophils, it is likely that advances in the genetics and genomics of Neisseria spp., neutrophil cell biology and in vivo systems for investigat ing innate immune function will contribute to refining and addressing these questions in the near future.
